Skip to main content
VCbacked
Log inGet Started

Lumen Bioscience

Seattle, United States

Lumen Bio discovers, develops, and manufactures biologic drugs and vaccine candidates for various diseases.

$30.0M raised
Oct 2025
Series C
BiopharmaBiotechnologyLife Science

Top Investors

Bill & Melinda Gates FoundationCARB-XUS Department of EnergyU.S. Department of DefenseWestRiver Group

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Lumen Bioscience

How much funding has Lumen Bioscience raised?
Lumen Bioscience has raised $30.0M in total funding. The most recent round was Series C. The last funding was announced in October 2025.
Who are Lumen Bioscience's investors?
Lumen Bioscience's investors include Bill & Melinda Gates Foundation, CARB-X, US Department of Energy, U.S. Department of Defense, WestRiver Group.
Where is Lumen Bioscience headquartered?
Lumen Bioscience is headquartered in Seattle, United States.
What does Lumen Bioscience do?
Lumen Bio discovers, develops, and manufactures biologic drugs and vaccine candidates for various diseases.
What stage is Lumen Bioscience at?
Lumen Bioscience is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Lumen Bioscience — Funding & Investors." VCBacked, October 8, 2025, https://www.vcbacked.co/company/lumen-bioscience. Accessed June 4, 2026.
APA
VCBacked. (2025). Lumen Bioscience — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/lumen-bioscience
Wikipedia (cite web)
{{cite web |title=Lumen Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/lumen-bioscience |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego